002950.SZ SHZ
Allmed Medical Products Co.,Ltd
1W: -1.0%
1M: -7.1%
3M: -8.3%
YTD: -22.9%
1Y: -12.0%
3Y: -16.8%
5Y: -45.3%
¥8.54 ($1.27)
+0.12 (+1.43%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$5.1B
-0.5% ▼
5Y CAGR: +9.9%
Total Liabilities
$1.6B
-14.0% ▼
5Y CAGR: +8.0%
Shareholders Equity
$3.4B
+7.8% ▲
5Y CAGR: +10.9%
Cash & Investments
$668M
+35.3% ▲
5Y CAGR: +22.4%
Total Debt
$584M
-35.2% ▼
5Y CAGR: +0.0%
Net Debt
-$1M
-100.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.3B | $678M | $522M | $397M | $585M |
| Short-Term Investments | $36M | $8M | $265M | $97M | $83M |
| Cash & ST Investments | $1.3B | $687M | $787M | $494M | $668M |
| Net Receivables | $342M | $532M | $522M | $493M | $525M |
| Inventory | $707M | $847M | $877M | $707M | $615M |
| Other Current Assets | $258M | $177M | $213M | $56M | $63M |
| Total Current Assets | $2.8B | $2.2B | $2.4B | $1.8B | $1.9B |
| Property, Plant & Equip. | $1.3B | $1.6B | $2.0B | $2.0B | $1.8B |
| Goodwill & Intangibles | $220M | $261M | $312M | $301M | $278M |
| Long-Term Investments | $368M | $751M | $611M | $952M | $815M |
| Other Non-Current Assets | $129M | $82M | $358M | $9M | $159M |
| Total Non-Current Assets | $2.0B | $2.8B | $3.3B | $3.3B | $3.1B |
| Total Assets | $4.9B | $5.0B | $5.7B | $5.1B | $5.1B |
| — Liabilities — | |||||
| Accounts Payable | $144M | $254M | $897M | $204M | $361M |
| Short-Term Debt | $1.1B | $1.2B | $792M | $750M | $494M |
| Deferred Revenue | $235M | $158M | $129M | $0 | $0 |
| Other Current Liabilities | $1M | $65M | $248M | $259M | $96M |
| Total Current Liabilities | $1.5B | $1.6B | $2.1B | $1.3B | $1.1B |
| Long-Term Debt | $100M | $128M | $111M | $146M | $89M |
| Other Non-Current Liab. | $0 | $0 | $5M | $197M | $0 |
| Total Non-Current Liabilities | $468M | $614M | $550M | $548M | $503M |
| Total Liabilities | $1.9B | $2.3B | $2.6B | $1.9B | $1.6B |
| — Equity — | |||||
| Common Stock | $633M | $633M | $633M | $633M | $633M |
| Retained Earnings | $1.6B | $1.5B | $1.7B | $1.7B | $2.0B |
| Accumulated OCI | $126M | $113M | $231M | $0 | $302M |
| Total Stockholders Equity | $2.9B | $2.8B | $3.1B | $3.2B | $3.4B |
| Total Liabilities & Equity | $4.9B | $5.0B | $5.7B | $5.1B | $5.1B |
| — Key Metrics — | |||||
| Total Debt | $1.2B | $1.3B | $933M | $900M | $584M |
| Net Debt | -$116M | $611M | $411M | $503M | -$1M |
| Total Investments | $403M | $759M | $875M | $1.0B | $898M |